Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura

Published:2016-06-16 Issue:24 Volume:127 Page:3092-3094
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Page Evaren E.¹²,Kremer Hovinga Johanna A.³,Terrell Deirdra R.¹,Vesely Sara K.¹,George James N.¹²

Affiliation:

1. Department of Biostatistics and Epidemiology, College of Public Health and

2. Hematology-Oncology Section, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK; and

3. Department of Hematology and Central Hematology Laboratory, University Hospital of Bern, Department of Clinical Research, University of Bern, Bern, Switzerland

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/127/24/3092/1394229/3092.pdf

Reference8 articles.

1. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.;Lim;Blood,2015

2. Rituximab in autoimmune thrombotic thrombocytopenic purpura: a success story.;Froissart;Eur J Intern Med,2015

3. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.;Scully;Blood,2011

4. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange.;Froissart;Crit Care Med,2012

5. Survival and relapse in patients with thrombotic thrombocytopenic purpura.;Kremer Hovinga;Blood,2010

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report;Journal of Medical Case Reports;2024-07-05

2. Nierenbeteiligung bei thrombotischer Mikroangiopathie;Nephrologie aktuell;2024-07

3. IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES.;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

4. Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura;Journal of Thrombosis and Haemostasis;2024-02

5. Plasma cell‐directed therapy strategies in immune‐mediated thrombotic thrombocytopenic purpura (iTTP);Transfusion;2024-01-18